A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

Conditions:   Microsatellite High Cancers;   Peritoneal Mesothelioma;   Extrapulmonary High Grade;   Neuroendocrine Carcinomas;   Cervical Carcinoma;   Hodgkin's Lymphoma;   Pleural Mesothelioma;   Small Cell Lung Cancer Intervention:   Drug: XmAb20717 Sponsor:   M.D. Anderson Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials